SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Fennec Pharmaceuticals Inc. backtest

10 trend-following strategies were compared on the full daily history of Fennec Pharmaceuticals Inc.. 6 beat buy-and-hold CAGR; 볼린저 밴드 돌파 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is 볼린저 밴드 돌파 (CAGR 5.6%, MDD -17.3%).

Data 2017-09-15 ~ 2026-07-31daily bars 2,230 (8.9 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

6 of 10 beat buy and hold (CAGR -2.6%, drawdown -77.0%).

Sharpe leader (same as main): 볼린저 밴드 돌파 — CAGR 5.6%, MDD -17.3%, Sharpe 0.60, 5% exposure.

CAGR reference leader: MACD — CAGR 8.9%, MDD -50.1%, exposure 52%.

Return/drawdown alternative: 볼린저 밴드 돌파 — CAGR is 8.2%p higher than buy and hold, while drawdown improves by 59.7%p (CAGR 5.6%, MDD -17.3%, exposure 5%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
볼린저 밴드 돌파
n=20, k=3.2
5.6%-17.3%0.600.321.6x105%
MACD
fast=17, slow=45, signal=23
8.9%-50.1%0.410.182.1x8252%
Donchian 채널 돌파
entryN=26, exitN=13
5.4%-46.1%0.330.121.6x4038%
ADX / DI 방향성
period=30, threshold=14
4.0%-63.6%0.320.061.4x5538%
Supertrend
period=35, mult=3.6
0.8%-66.3%0.250.011.1x2956%
EMA 크로스오버
fast=18, slow=31
0.7%-69.0%0.250.011.1x4550%
SMA 크로스오버
fast=76, slow=155
-5.4%-74.6%0.12-0.070.6x1748%
ROC 모멘텀
n=117, threshold=0
-9.8%-77.5%0.00-0.130.4x6549%
Parabolic SAR
step=0.01, maxStep=0.16
-11.5%-83.0%-0.04-0.140.3x11248%
Keltner 채널 돌파
emaPeriod=48, atrPeriod=11, mult=2.9
-7.3%-66.2%-0.12-0.110.5x2021%
Buy and hold-2.6%-77.0%0.27-0.030.8x1100%
1x 2018 2020 2022 2024 2026 MACD볼린저 밴드 돌파Buy and hold
볼린저 밴드 돌파 (Sharpe leader), MACD (CAGR reference), Buy and hold.
0% -19% -38% -58% -77% 2018 2020 2022 2024 2026 Buy and holdMACD볼린저 밴드 돌파
볼린저 밴드 돌파 maximum drawdown -17.3% (2023-12-28 → 2026-06-08), prior peak not yet recovered.

Rules of the top strategy

Breaking above the upper band (average plus a multiple of volatility) signals a strong move up.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next